Zhejiang Cancer Hospital
🇨🇳China
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2011-11-02
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01463501
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer
- First Posted Date
- 2011-02-08
- Last Posted Date
- 2011-02-08
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT01291823
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-12-10
- Last Posted Date
- 2014-07-29
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT01258192
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer
- First Posted Date
- 2010-08-04
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT01175460
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer
- First Posted Date
- 2010-08-04
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT01175447
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2010-07-08
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 134
- Registration Number
- NCT01158144
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2010-07-08
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT01158170
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2010-05-17
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT01091376
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2011-02-24
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT00886678
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Zoladex Plus Tamoxifen in Breast Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2011-08-08
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT00827307
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
© Copyright 2024. All Rights Reserved by MedPath